The APJs Speak on Practice, Policy, and Procedure in the World of Pharmaceutical Patent Validity Changes

April 27, 2022 2:15pm

Honorable Jacqueline Wright Bonilla
Deputy Chief Administrative Patent Judge
Patent Trial & Appeal Board


Honorable Michelle N. Ankenbrand
Senior Lead Administrative Patent Judge
Patent Trial & Appeal Board



John J. Molenda
Steptoe & Johnson LLP

Elizabeth S. Weiswasser
Weil, Gotshal & Manges LLP

  • Taking stock of the latest developments related to the PTAB’s expanded use of discretionary denials
  • Reviewing the latest stats at PTAB, highlighting bio/pharma cases
  • Outlining the latest developments on pilot programs at PTAB
    • Legal Experience and Advancement Program (LEAP)
    • Fast-Track Appeals
    • Motions to Amend (MTAs) in AIA proceedings
  • Detailing recent rules at PTAB
    • New rule relating to institution of trials (as it relates to SAS, expert testimony, and sur-replies)
    • New rule relating to burdens of persuasion in MTAs
  • Interpreting PTAB precedent and other information
    • Newly designated precedent at PTAB
    • New memorandum regarding indefiniteness approach in AIA proceedings